Articles
Ambassador for science
A passionate advocate for science, Professor Lyn Beazley shares some of the exceptional and continuing contributions she has made to Australian science over a career that began with a passion for biology. [ + ]
UTS boffins develop blood test for oral cancers
Researchers from UTS have developed a fast and easy way to administer a blood test for detecting early warning signs of oral cancers. [ + ]
ResMed wins sales ban against APEX in Germany
A German court has issued an injunction prohibiting Taiwan's APEX Medical from local sales of two face masks found to infringe on ResMed (ASX:RMD) patents. [ + ]
Patrys commences CAR T cell research program
Patrys (ASX:PAB) has started collaborative research into genetically engineering T cells against novel anticancer targets using its IgM antibodies. [ + ]
Brocade to handle genome facility's big data
Driven by the growth of genomic data sets, the Australian Genome Research Facility is deploying a high-performance 10 Gigabit Ethernet (GbE) core network across its entire estate, with its Melbourne node the first to go live with new switching infrastructure from Brocade. [ + ]
Funding scientific research - a national investment, not an expense
Dr Steve Winslade reflects on the current state of funding for Australian scientific research. [ + ]
Biotron's BIT225 reverses immune impairment in HIV
New data from a trial of Biotron's (ASX:BIT) BIT225 in HIV show that patients treated daily demonstrated a reduction in sCD163 levels in the blood. [ + ]
Perth's Orthocell raises $8m in oversubscribed IPO
Orthocell has completed an IPO, raising $8m to help market and prepare approvals for its regenerative medicine products, while paving the way for an ASX listing in August. [ + ]
Starpharma close to first major revenues
Ansell has secured Australian certification for a line of condoms coated with Starpharma's (ASX:SPL) VivaGel, and aims to launch a line of products in the next few months. [ + ]
bioCSL distributing transfusion testing tech in ANZ
CSL subsidiary bioCSL (ASX:CSL) has commenced distribution of Immucor's blood-transfusion compatibility testing technology Capture in Australia and New Zealand. [ + ]
The secret to twisting light
Scientists from the Australian National University (ANU) have uncovered the secret to twisting light at will - the latest step in the development of photonics. Their research has been published in the journal Nature Communications. [ + ]
The debate on criminalising research fraud
The BMJ has featured an article in which two experts go head to head discussing the potential criminalisation of research fraud. [ + ]
Inexpensive assay detects fake malaria drugs
Chemists from Oregon State University (OSU) have created a simple, inexpensive assay which can tell whether or not one of the primary drugs being used to treat malaria is genuine. [ + ]
Imugene picks exclusive manufacturer for HER-Vaxx
Imugene (ASX:IMU) has selected Swiss-based virosome specialist Mymetics as the exclusive manufacturer for its HER-Vaxx cancer immunotherapy product. [ + ]
Prima picks up US patent for cancer treatment CVac
The US patent office has approved Prima BioMed's (ASX:PRR) application for a patent protecting autologous cancer treatment candidate CVac. [ + ]
